You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上海醫藥(601607.SH):2019年股票期權激勵計劃獲上海國資委批覆
格隆匯 11-11 18:13

格隆匯11月11日丨上海醫藥(601607.SH)公佈,今日,公司收到上海市國有資產監督管理委員會出具的《關於同意上海醫藥實施股票期權激勵計劃的批覆》(滬國資委分配[2019]297號),主要內容如下:

1、原則同意《上海醫藥集團股份有限公司2019年股票期權激勵計劃(草案)》,請按有關規定提交股東大會審議。

2、如獲股東大會審議通過,請你公司按照上述文件要求,嚴格執行授予和行權條件,健全績效考核體系,強化責任約束監督機制,合理調控激勵收益水平。

3、請你公司切實加強對上海醫藥實施股票期權激勵計劃的動態管理,並將激勵計劃推進情況、上市公司股本總數及國有控股持股比例變化情況及時報我委備案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account